Prion diseases, such as Creutzfeldt-Jakob Disease (CJD), are fast-moving, fatal dementia syndromes associated with the formation of aggregates of the prion protein, PrP. How these aggregates form within and kill brain cells ...
Dec 22, 2021
0
254
Remote monitoring of health-related behavior with wearable sensor technology is feasible for people with complex health conditions, shows a recent University of Waterloo study.
Dec 20, 2021
0
27
A common gene mutation for Parkinson's disease drives mislocalization of iron in activated microglia, according to a new study publishing December 16th in the open-access journal PLOS Biology, by Mark Cookson of the National ...
Dec 16, 2021
0
172
NFL players are four times more likely to die of Lou Gehrig's disease (ALS) than other people, new research finds, adding to known links between football-related head injuries and brain diseases, including Alzheimer's, Parkinson's ...
Dec 16, 2021
0
5
Scientists have determined for the first time the structure of the molecule associated with amyotrophic lateral sclerosis (ALS) and multiple other neurodegenerative diseases. The scientists at the Medical Research Council ...
Dec 8, 2021
0
148
While chronic traumatic encephalopathy (CTE) cannot yet be diagnosed during life, a new study provides the best evidence to date that a commonly used brain imaging technique, magnetic resonance imaging (MRI), may expedite ...
Dec 8, 2021
0
10
Microglia, the immune cells of the brain, form the first line of defense against neurodegenerative diseases and traumatic brain injuries. They maintain brain homeostasis, the stable condition necessary for survival, by acting ...
Dec 7, 2021
0
4
A gene mutation linked to Alzheimer's disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine. The team also found that ...
Dec 1, 2021
0
57
Losing memory is a hallmark of Alzheimer's, a symptom of the disease that depletes a patient's quality of life. Improving memory and slowing cognitive changes caused by the disease is an ongoing challenge for researchers ...
Nov 5, 2021
0
82
Sio Gene Therapies, a clinical-stage company focused on developing gene therapies for neurodegenerative diseases, presented positive interim data from its ongoing Phase I/II study of AXO-AAV-GM1, an adeno-associated viral ...
Nov 3, 2021
0
4
